Skip to content

Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments

Retrospective Case-control Study of Central Line Botriomycoma in Children on Home Parenteral Nutrition: Epidemiology, Risk Factors, Treatments

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06708689
Enrollment
240
Registered
2024-11-27
Start date
2022-04-01
Completion date
2025-03-03
Last updated
2024-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotics, Botriomycoma, Central Line, Home Parenteral Nutrition, Infection, Intestinal Failure, Sepsis

Brief summary

Botriomycomas are frequent benign tumors in children. Their appearance on the central catheter orifice is a known event in clinical practice, but one that has been little studied. This lesion could lead to changes in pathways and an increase in the number of sepsis events, which would promote thrombosis and thus depletion of venous capital in patients who have been dependent on a central line for many years. This study is a pilot study which will enable us to better identify the risk factors for the development of such a tumour, and to take stock of the different treatments used and their respective efficacy.

Interventions

None listed

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* home parenteral nutrition patients * never diagnosed with an episode of botriomycoma on their central line * 0 to 18 years of age at diagnosis

Exclusion criteria

* Botriomycoma more than 10 years old at time of data collection (or lack of data) * Patient over 18 years of age * Not on home parenteral nutrition patients

Design outcomes

Primary

MeasureTime frameDescription
Appearance of BotryomycomaFrom first diagnosis through a follow-up period of 2 years.genetic characteristics (origin, phototype), local factors (mechanical, infectious), and general factors (history of sepsis).
Recurrence of BotryomycomaFrom first diagnosis through a follow-up period of 2 years.analyze risk factors for recurrence and evolution under different treatments.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026